Guangdong Hybribio Biotech Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 606.63 million compared to CNY 2,842.53 million a year ago. Revenue was CNY 606.63 million compared to CNY 2,842.53 million a year ago.

Net income was CNY 122.84 million compared to CNY 978.31 million a year ago. Basic earnings per share from continuing operations was CNY 0.1881 compared to CNY 1.4929 a year ago. Diluted earnings per share from continuing operations was CNY 0.1881 compared to CNY 1.4929 a year ago.